Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of KAR5585 in healthy adults
NCT02746237Phase 1Completed
- Sponsor
- Karos Pharmaceuticals
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing KAR5585 with Placebo (2 arms). Primary endpoints: Number of participants with abnormal physical exam results, Number of participants with abnormal hematology values and 3 more. Started Nov 2015; status: completed.
02
Drugs
rodatristat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02746237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746237.